← back to search

Satyajit Kosuri

University of Chicago · US
Area of research
Hematology · Oncology
Research interest
Research interests include Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, CAR-T cell therapy research, and Chronic Myeloid Leukemia Treatments.
h-index
16
citations
1,198
works
126
NIH funding
primary concept
email

Recent publications

Intrathecal chemotherapy for ciltacabtagene autoleucel–associated movement and neurocognitive toxicity
Blood Advances 2025cited by 9position: middledoi
Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial
Blood 2025cited by 8position: middledoi
Optimization of older adults by a geriatric assessment–guided multidisciplinary clinic before CAR T-cell therapy
Blood Advances 2024cited by 17position: middledoi
Utility or futility? A contemporary approach to allogeneic hematopoietic cell transplantation for <i>TP53-</i>mutated MDS/AML
Blood Advances 2023cited by 42position: lastdoi
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies
Blood Advances 2022cited by 48position: middledoi
COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter
Leukemia 2020cited by 54position: middledoi
Clinical outcomes of <i>IDH2</i>‐mutated advanced‐phase Ph‐negative myeloproliferative neoplasms treated with enasidenib
British Journal of Haematology 2020cited by 44position: middledoi
Unexpected Toxicities When Nivolumab Was Given as Maintenance Therapy following Allogeneic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation 2020cited by 32position: middledoi
Dose escalation prophylactic donor lymphocyte infusion after T-cell depleted matched related donor allogeneic hematopoietic cell transplantation is feasible and results in higher donor chimerism, faster immune re-constitution, and prolonged progression-free survival
Bone Marrow Transplantation 2020cited by 17position: middledoi
Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults
Blood Advances 2019cited by 97position: middledoi
A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia
Journal of Hematology & Oncology 2018cited by 68position: middledoi
Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation 2017cited by 17position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael R. Bishop · University College London8 papers (2018–2025)Andrew Artz · City Of Hope National Medical Center6 papers (2018–2024)Wendy Stock · Leukemia Research Foundation5 papers (2018–2020)Hongtao Liu · University of Wisconsin–Madison5 papers (2018–2020)Peter A. Riedell · Janssen (United States)4 papers (2019–2024)Justin Kline · Palmetto Hematology Oncology4 papers (2019–2024)Olatoyosi Odenike · Leipzig University4 papers (2018–2020)Andrzej Jakubowiak · Palmetto Hematology Oncology3 papers (2019–2025)Benjamin A. Derman · Comprehensive Cardiovascular3 papers (2019–2025)Mylove Mortel · University of Illinois Chicago2 papers (2019–2024)Mariam T. Nawas · University of Illinois Chicago2 papers (2023–2024)Michael J. Thirman · University of Chicago Medical Center2 papers (2018–2020)Sang Mee Lee · Alteogen (South Korea)2 papers (2019–2020)Keriann Kordas · University of Chicago2 papers (2019–2024)Lucy A. Godley · Northwestern University2 papers (2018–2022)Roni Tamari · Weill Cornell Medicine2 papers (2017–2025)Noreen Fulton · University of Chicago2 papers (2018–2020)Amy Wang · NorthShore University HealthSystem2 papers (2018–2020)Ankur Varma · Rush University Medical Center1 papers (2020–2020)Caner Saygin · University of Illinois Chicago1 papers (2022–2022)